Target intelligence / Profile preview

Taste receptor type 2 member 31 (TAS2R31)

Target
TAS2R31
Molecular classification
G protein-coupled receptor, Receptor, Bitter taste receptor
01

Overview

Taste receptor type 2 member 31 (TAS2R31) is a G protein-coupled receptor primarily involved in the perception of bitter taste in humans. Encoded by the TAS2R31 gene, this receptor is expressed in taste receptor cells as well as extra-oral tissues such as airway smooth muscle. It is activated by various bitter compounds, including the artificial sweeteners saccharin and acesulfame K. In airway smooth muscle, activation of TAS2R31 can lead to increased intracellular calcium, opening potassium channels and resulting in smooth muscle relaxation and bronchodilation. Polymorphisms in TAS2R31 influence sensitivity to the bitterness of certain sweeteners, and the gene has been associated with specific disease states such as inflammatory bowel disease 11 and Charcot-Marie-Tooth disease, axonal, type 2N. The receptor operates via the canonical GPCR signaling cascade that includes Gα-gustducin, phospholipase Cβ2, and downstream ion channels, ultimately resulting in cell depolarization and neurotransmitter release[1][2][4].

Other names
Taste 2 receptor member 31TAS2R31T2R31TAS2R44T2R44T2R53Taste receptor type 2 member 44Taste receptor type 2 member 53
02

Mechanism of action

Drugs (such as saccharin and acesulfame K) act as agonists, activating the receptor and initiating G protein-coupled signaling that results in increased intracellular calcium, ultimately mediating physiological responses such as taste perception or smooth muscle relaxation[1][2][4]. Antagonists (e.g., GIV3727) inhibit receptor activity by binding to the same or overlapping binding pocket[4].

03

Biological functions

Signal transductionSensory perception of taste (bitterness)Smooth muscle relaxation (bronchodilation)Sensing chemical composition of the gastrointestinal content
04

Disease associations

Inflammatory bowel diseaseCharcot-Marie-Tooth disease, axonal, type 2NPotential role in airway diseases through modulation of bronchodilation
05

Safety considerations

No notable direct therapeutic safety concerns documented; as a taste receptor, its primary concern is off-target taste modulation or effects on non-gustatory tissues (such as airway smooth muscle).
06

Interacting drugs

Saccharin

3 more in the full profile.

07

Biomarkers

Polymorphisms in TAS2R31 gene are associated with interindividual differences in the perceived bitterness of sweeteners such as acesulfame potassium[1].

Beyond the preview

Go deeper on Taste receptor type 2 member 31 (TAS2R31).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Taste receptor type 2 member 31 (TAS2R31).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call